Anisha Wharton is the Vice President of Regulatory Affairs at AVEO Oncology, an LG Chem company, where she brings over 21 years of strategic regulatory leadership spanning global drug development, product registration, and lifecycle management across both biologics and pharmaceutical portfolios. As a strategic leader, she is responsible for guiding AVEO through complex regulatory frameworks
Deb Wall serves as the Senior Director, Human Resources at AVEO Oncology, an LG Chem company, and brings more than a decade of experience leading the human resource functions of both private and public companies. Ms. Wall brings deep human resources and culture-building experience to AVEO in which she seeks to build a “People First”
Dr. Adebunmi (Bunmi) Urakpo serves as Vice President of Pharmacovigilance for AVEO Oncology, an LG Chem Company, bringing over 20 years of experience in drug safety and pharmacovigilance, clinical research, and public health. Dr. Urakpo most recently served as a Pharmacovigilance and Drug Safety Consultant at NADDBio LLC (“NADDBio”), a clinical-stage R&D consultancy firm. Prior
Kevin Peacock joined AVEO Oncology in 2019, bringing over 20 years of extensive pharmaceutical experience to AVEO’s commercial organization. Mr. Peacock currently serves as Senior Vice President of Marketing and Business Analytics at AVEO Oncology, an LG Chem company, leading the overall brand strategy for FOTIVDA®, while also overseeing the brand’s data analytics and insights.
Michael Palliola currently serves as Vice President, Thought Leader Engagement & Strategic Partnerships at AVEO Oncology, an LG Chem Company. He brings over 20 years of commercial experience in the biotech/pharmaceutical space, primarily in launch stage organizations. During his career, Michael has held oncology roles in sales, sales training, US/Global marketing, brand management, and KOL
Greg Oehrtman brings over 20 years of Drug Development experience to his role returning to AVEO Oncology, an LG Chem company, after 8 years. Dr. Oehrtman has held roles of increasing seniority in Drug Development and Manufacturing at Quintiles/Catalent, Amylin, Stealth Biotherapeutics, and Dicerna. He has led both drug substance and product development and manufacturing from
Jason Noto brings over 25 years of broad commercial leadership experience to his role as Senior Vice President of Market Access & Alliance Management at AVEO Oncology, an LG Chem company. Prior to joining AVEO, Jason served as Vice President at 1798 Consultants, a strategic market access consultancy specializing in integrated channel strategy, patient support
Dr. Claudia Lebedinsky serves as Senior Vice President, Head of Clinical Development of AVEO Oncology, an LG Chem company, bringing more than 20 years of experience in oncology and clinical development to the organization. Dr. Lebedinsky most recently served as Vice President, Head of Clinical Development at Sumitomo Pharma Oncology (Sumitomo), where she led the
Dr. Bo Jin serves as Vice President of Biostatistics and Data Management at AVEO Oncology, an LG Chem company, bringing over 20 years of industry experience in biostatistics, data management, programming, and data sciences. Dr. Jin most recently served as Vice President of Biostatistics and Programming at SinoCellTech Group Limited (SinoCell), where he was responsible
Mr. Jeong serves as as Chief Financial Officer of AVEO Oncology, an LG Chem company. Mr. Jeong joins AVEO from its parent company, LG Chem, Ltd. (“LG Chem”), where he has served as a financial and accounting officer since 1999. During his time at LG Chem, Mr. Jeong has served as the financial director and